Analyst: Bavarian drug could have a strong position, but…
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4706554.ece/ALTERNATES/schema-16_9/Prostata.jpg)
Danish company Dandrit is developing a cancer vaccine, as is another Danish company, Bavarian Nordic. US company Dendreon’s own vaccine, Provenge, has disappointed, while Johnson & Johnson’s Zytiga is performing great.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.